WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Generated Narrative: Task Task-Felleskatalogen-CPOD-MPD-1
status: Requested
intent: proposal
priority: Routine
authoredOn: 2023-08-28
lastModified: 2023-08-28
input
type: Medicinal Product for PhPID request
input
type: Ingredient for PhPID request
input
type: Marketing Auth Holder for PhPID request
value: Organization MAH 1
Generated Narrative: MedicinalProductDefinition #ID-ACC470D6-0B3C-4082-9494-775FB6D2048C
identifier:
http://legemiddelverket.no/FEST/LegemiddelMerkevareID
/ID_ACC470D6-0B3C-4082-9494-775FB6D2048Ctype: Medicinal Product
domain: Human use
status: Active
combinedPharmaceuticalDoseForm: Subkutan bruk
attachedDocument: SPC/123
Contacts
Contact Organization MAH 1 name
productName: Eklira Genuair
Usages
Country Jurisdiction Language Norway Norway Norwegian
Generated Narrative: Ingredient #ID-1C149B52-D662-4CE0-9FA3-79865521F9C6
status: Draft
role: Active
substance
Codes
Concept OMEPRAZOLE Strengths
Presentation[x] TextPresentation 322 ug/1 IU 322 µg
Generated Narrative: Organization #mah1
active: true
type: Non-Healthcare Business or Corporation
name: MAH 1